CGD experts discuss MVAC blueprint to create market for new TB drugs

Center for Global Development (CGD): A Final MVAC Blueprint — and the Start of an R&D Revolution?

Rachel Silverman, policy fellow at CGD, and colleagues discuss the Market-Driven, Value-Based Advance Commitment (MVAC) proposal, “a mechanism to create and guarantee a market for better TB treatment, if and when such a treatment becomes available,” and highlight a blueprint outlining its rationale and basic structure. The authors write, “We believe the MVAC is an innovative mechanism that can help to kickstart the R&D revolution needed to tackle diseases of the poor whilst also creating the beginnings of a marketplace for innovative products in emerging markets. We are proposing first use of this mechanism for new drugs for TB”.

Source: Kaiser Daily Global Health Policy Report

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By Center for Global Development

Published: Feb. 6, 2020, 11:40 p.m.

Last updated: Feb. 7, 2020, 11:45 p.m.

Print Share